Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile

American Journal of Transplantation

Volumn 11, Issue 3, 2011, Pages 429-438

  Le Texier, L ^a   Thebault, P ^a   Lavault, A ^a   Usal, C ^a   Merieau, E ^a   Quillard, T ^a   Charreau, B ^a   Soulillou, J P ^a   Cuturi, M C ^a   Brouard, S ^a   Chiffoleau, Elise ^a  

^a NONE

Author keywords

Alloantibodies; B cell tolerance; Tolerance immune

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BIOACCUMULATION; CELL INFILTRATION; CELL PROTECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENDOTHELIUM CELL; GERMINAL CENTER; GRAFT RECIPIENT; GRAFT SURVIVAL; IMMUNOREGULATION; IN VITRO STUDY; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; FLOW CYTOMETRY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN SWITCH REGION; ISOANTIBODIES; MALE; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TH2 CELLS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 79951992393     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03336.x     Document Type: Article

References (49)

1. Libby P, Pober J. Chronic rejection. Immunity 2001; 14: 387-397. (Pubitemid 32441591)
2. Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574-582. (Pubitemid 32180027)
3. Hidalgo LG, Campbell PM, Sis B et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9: 2532-2541.
4. Einecke G, Sis B, Reeve J et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
5. Piazza A, Poggi E, Borrelli L et al. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: Posttransplant analysis using flow cytometric techniques. Transplantation 2001; 71: 1106-1112.
6. Haririan A, Kiangkitiwan B, Kukuruga D et al. The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy. Am J Transplant 2009; 9: 2758-2767.
7. Billing H, Rieger S, Ovens J et al. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients. Transplantation 2008; 86: 1214-1221.
8. Everly MJ, Everly JJ, Susskind B et al. Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation 2008; 86: 1754-1761.
9. Zarkhin V, Chalasani G, Sarwal MM. The yin and yang of B cells in graft rejection and tolerance. Transplant Rev (Orlando); 24: 67-78.
10. Roussey-Kesler G, Giral M, Moreau A et al. Clinical operational tolerance after kidney transplantation. Am J Transplant 2006; 6: 736-746. (Pubitemid 43345011)
11. Martinez-Llordella M, Lozano JJ, Puig-Pey I et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008; 118: 2845-2857.
12. Louis S, Braudeau C, Giral M et al. Contrasting CD25hiCD4+ T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006; 81: 398-407. (Pubitemid 43255726)
13. Pallier A, Hillion S, Danger R et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010; 78: 503-513.
14. Sagoo P, Perucha E, Sawitzki B et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010; 120: 1848-1861.
15. Newell KA, Asare A, Kirk AD et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120: 1836-1847.
16. Chiffoleau E, Beriou G, Dutartre P, Usal C, Soulillou JP, Cuturi MC. Induction of donor-specific allograft tolerance by short-term treatment with LF15-0195 after transplantation. Evidence for a direct effect on T cell differentiation. Am J Transplant. 2002; 2: 745-757. (Pubitemid 36342617)
17. Chiffoleau E, Beriou G, Dutartre P, Usal C, Soulillou JP, Cuturi MC. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. J Immunol. 2002; 168: 5058-5069. (Pubitemid 34495969)
18. Heslan JM, Renaudin K, Thebault P, Josien R, Cuturi MC, Chiffoleau E. New evidence for a role of allograft accommodation in long-term tolerance. Transplantation 2006; 82: 1185-1193. (Pubitemid 44748021)
19. Thebault P, Condamine T, Heslan M et al. Role of IFNgamma in allograft tolerance mediated by CD4+CD25+ regulatory T cells by induction of IDO in endothelial cells. Am J Transplant 2007; 7: 2472-2482. (Pubitemid 47561604)
20. Ono K, Lyndsey ES. Improved technic of heart transplantation in rats. J Thorac Cardiovasc Surg 1968; 57: 225-229.
21. Soulillou J-P, Blandin F, Günther E, Lemoine V. Genetics of the blood transfusion effect on heart allografts in rats. Transplantation 1984; 38: 63-67. (Pubitemid 14092466)
22. Ballet C, Renaudin K, Degauque N et al. Indirect CD4+ TH1 response, antidonor antibodies and diffuse C4d graft deposits in long-term recipients conditioned by donor antigens priming. Am J Transplant 2009; 9: 697-708.
23. Charreau B, Cassard A, Tesson L et al. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Transplantation 1994; 58: 1222-1229.
24. Louvet C, Heslan JM, Merieau E, Soulillou JP, Cuturi MC, Chiffoleau E. Induction of Fractalkine and CX3CR1 mediated by host CD8+ T cells in allograft tolerance induced by donor specific blood transfusion. Transplantation 2004;78:1259-1266. (Pubitemid 39507962)
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method. Methods 2001;25:402-408. (Pubitemid 34164012)
26. Benson MJ, Dillon SR, Castigli E et al. Cutting edge: The dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol 2008;180:3655-3659.
27. Thebault P, Lhermite N, Tilly G et al. The C-type lectin-like receptor CLEC-1, expressed by myeloid cells and endothelial cells, is upregulated by immunoregulatory mediators and moderates T cell activation. J Immunol 2009;183:3099-3108.
28. Sivozhelezov V, Braud C, Giacomelli L et al. Immunosuppressive drug-free operational immune tolerance in human kidney transplants recipients. Part II. Non-statistical gene microarray analysis. J Cell Biochem 2008; 103: 1693-1706. (Pubitemid 351501903)
29. Koshiba T, Kitade H, Van Damme B et al. Regulatory cell-mediated tolerance does not protect against chronic rejection. Transplantation 2003; 76: 588-596. (Pubitemid 37013268)
30. Baddoura FK, Nasr IW, Wrobel B, Li Q, Ruddle NH, Lakkis FG. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplant 2005; 5: 510-516. (Pubitemid 40313342)
31. Thaunat O, Field AC, Dai J et al. Lymphoid neogenesis in chronic rejection: Evidence for a local humoral alloimmune response. Proc Natl Acad Sci USA 2005; 102: 14723-14728. (Pubitemid 41457123)
32. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312-2323.
33. Wehner J, Morrell CN, Reynolds T, Rodriguez ER, Baldwin WM, 3rd. Antibody and complement in transplant vasculopathy. Circ Res 2007; 100: 191-203. (Pubitemid 46208719)
34. Coupel S, Leboeuf F, Boulday G, Soulillou JP, Charreau B. RhoA activation mediates phosphatidylinositol 3-kinase-dependent proliferation of human vascular endothelial cells: An alloimmune mechanism of chronic allograft nephropathy. J Am Soc Nephrol 2004; 15: 2429-2439. (Pubitemid 39159343)
35. Brouard S, Otterbein LE, Anrather J et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015-1026.
36. Quillard T, Coupel S, Coulon F et al. Impaired Notch4 activity elicits endothelial cell activation and apoptosis: Implication for transplant arteriosclerosis. Arterioscler Thromb Vasc Biol 2008; 28: 2258-2265.
37. Kinderlerer AR, Pombo Gregoire I, Hamdulay SS et al. Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: A role for increased bilirubin and ferritin. Blood 2009; 113: 1598-1607.
38. Chang AT, Platt JL. The role of antibodies in transplantation. Transplant Rev (Orlando) 2009; 23: 191-198.
39. Zhang X, Reed EF. Effect of antibodies on endothelium. Am J Transplant 2009; 9: 2459-2465.
40. Yang J, Bernier SM, Ichim TE et al. LF15-0195 generates tolerogenic dendritic cells by suppression of NF-kappaB signaling through inhibition of IKK activity. J Leukoc Biol 2003; 74: 438-447. (Pubitemid 38040405)
41. Yokoyama K, Su Ih IH, Tezuka T et al. BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor. Embo J 2002; 21: 83-92.
42. Aiba Y, Yamazaki T, Okada T et al. BANK negatively regulates Akt activation and subsequent B cell responses. Immunity 2006; 24: 259-268.
43. Kozyrev SV, Abelson AK, Wojcik J et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008; 40: 211-216. (Pubitemid 351171404)
44. McGaha TL, Karlsson MC, Ravetch JV. FcgammaRIIB deficiency leads to autoimmunity and a defective response to apoptosis in Mrl-MpJ mice. J Immunol 2008; 180: 5670-5679.
45. Berek C, Berger A, Apel M. Maturation of the immune response in germinal centers. Cell 1991; 67: 1121-1129. (Pubitemid 121001525)
46. Ludwig-Portugall I, Hamilton-Williams EE, Gotot J, Kurts C. CD25+ T(reg) specifically suppress auto-Ab generation against pancreatic tissue autoantigens. Eur J Immunol 2009; 39: 225-233.
47. Evans JG, Chavez-Rueda KA, Eddaoudi A et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007; 178: 7868-7878. (Pubitemid 46898059)
48. Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN. B cell regulation of CD4+CD25 +T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol 2007; 178: 3447-3456. (Pubitemid 46417609)
49. Rafei M, Hsieh J, Zehntner S et al. A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat Med 2009; 15: 1038-1045.